Share on StockTwits

Anacor Pharmaceuticals (NASDAQ:ANAC) SVP Kirk R. Maples unloaded 3,000 shares of Anacor Pharmaceuticals stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $19.33, for a total transaction of $57,990.00. Following the completion of the sale, the senior vice president now directly owns 7,620 shares in the company, valued at approximately $147,295. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Anacor Pharmaceuticals (NASDAQ:ANAC) traded up 3.32% during mid-day trading on Friday, hitting $19.94. 470,539 shares of the company’s stock traded hands. Anacor Pharmaceuticals has a 52 week low of $3.00 and a 52 week high of $23.04. The stock’s 50-day moving average is $18.71 and its 200-day moving average is $13.9. The company’s market cap is $812.5 million.

Anacor Pharmaceuticals, Inc is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.